Linagliptin demonstrated clinically important HbA1c reduction, safety and tolerability profile in elderly people with Type 2 Diabetes with inadequate glycaemic control

INGELHEIM, Germany & INDIANAPOLIS, US - Thursday, August 15th 2013 [ME NewsWire]

(BUSINESS WIRE)-- For Non-US and Non-UK Media

Data published in The Lancet showed that elderly people with Type 2 Diabetes (T2D) treated for 24 weeks with the dipeptidyl peptidase-4 (DPP-4) inhibitor linagliptin, marketed by Boehringer Ingelheim and Eli Lilly and Company, experienced significant reductions in blood glucose levels (HbA1c) compared with those receiving placebo. In addition, the overall safety and tolerability profile of linagliptin was similar to placebo, with no significant difference in hypoglycaemia.1

"Elderly individuals comprise approximately 15% of people with Type 2 Diabetes2; however, few glucose-lowering agents have been investigated in this group. This evidence gap hinders clinical de ... Read more »

As part of "Aonak” Service

ABU DHABI, United Arab Emirates - Thursday, August 15th 2013 [ME NewsWire]

Brigadier Mohammed Abdullah Alwan, Director General of Residency and Foreigners Affairs, Ajman, organized a ceremony to honor volunteers working with the Sharjah City for Humanitarian Services (SCHS). The honoring is recognition of their efforts in inspecting the Directorate General’s facilities for the service of people with disabilities and submitting detailed observations that can be implemented to improve to improve the services provided to this integral part of society. This comes in line with the "Aonak” plan launched by the Directorate General of Residency and Foreigners Affairs, Ajman in 2009, to fulfill the needs and facilitate transactions for community members, particularly the elderly, persons with disabilities and patients.

Brigadier Alwan indicated that a total of 84 individuals benefitted from the "Aonak” service, since it was launched in 2009, while ... Read more »

Acquisition bolsters Quintiles’ small biopharma, oncology and medical device capabilities

RESEARCH TRIANGLE PARK, N.C - Thursday, August 15th 2013 [ME NewsWire]

(BUSINESS WIRE) To stay ahead of the diverse and evolving needs of its global customer base, Quintiles today announced it has signed an agreement to acquire Novella Clinical (Novella), a full-service clinical research organization (CRO) focused primarily on emerging oncology customers as well as those in the medical device and diagnostics sectors.

"The expertise and insight the Novella team brings will be a strong addition to our existing capabilities and help further differentiate Quintiles in an increasingly competitive marketplace,” said Paula Brown Stafford, President, Clinical Development at Quintiles. "Novella’s understanding of emerging companies, as well as our shared commitment to quality, customer service, and above all, the patients we ultimately serve, makes this acquisition a good fit for both ... Read more »

INGELHEIM, Germany - Thursday, August 15th 2013 [ME NewsWire]

    Over 950 patients have now been successfully enrolled in the pivotal Phase III HCVerso™ 1 and 2 trials
    The Phase III study programme includes treatment naïve patients, including those ineligible for interferon and patients with liver cirrhosis
    The milestone coincides with the New England Journal of Medicine publication of SOUND-C2: one of the largest interferon-free studies in genoytpe-1 HCV published to date, forming the basis of the HCVerso™ trials

(BUSINESS WIRE)

For media outside USA, UK and Canada only

Boehringer Ingelheim today announced that enrolment of over 950 treatment naïve genotype-1b patients in the pivotal Phase III interferon-free HCVerso™ 1 and 2 trials is complete.1,2 The trials are investigating the efficacy and safety of Boehringer Ingelheim’s second generation protease inhibitor faldaprevir* and NS5B polymerase inh ... Read more »

ABU DHABI, United Arab Emirates - Wednesday, August 14th 2013 [ME NewsWire]

The Higher Organizing Committee of the International Security, Safety and National Resilience exhibition and conference (ISNR Abu Dhabi 2014), announced that major specialized international companies from the region and the world will be taking part in the exhibition organized by the Ministry of the Interior in Abu Dhabi, in cooperation with REED Exhibitions, from April 1-3, 2014.

Commenting on the subject, Major General Staff Dr. Obeid Al Kutbi, Deputy Commander-in-chief of Abu Dhabi Police and Chairman of the Higher Organizing Committee stated that ISNR Abu Dhabi 2014 represents a platform that comprehensively covers issues of national security and safety under one roof. He also affirmed that the a number of prominent specialized leading local, regional and international companies have already confirmed their participation in the upcoming exhibition, namely; , Tawazun company; International Gold ... Read more »

Abu Dhabi, United Arab Emirates - Wednesday, August 14th 2013 [ME NewsWire]

Teams from the Abu Dhabi Civil Defense,  Rapid Intervention, and Emergency and Public Safety Department from t the Directorate General of Central Operations at Abu Dhabi Police, managed to extinguish  a fire that broke out at 12:30 pm on Wednesday in an under construction building in the Khaleej Al Arabi street towards Al Maqta area in Abu Dhabi. No injuries were reported.

Lieutenant Colonel Saeed Al Rashedi, Acting Head of Centers Department at the Abu Dhabi Directorate General of Civil Defense, said: "We cleared the roads leading to the scene of the accident to ensure the timely arrival of firefighters.  Ultimately, the fire was contained with high professionalism thanks to the efforts of firefighters’ teams, and investigations are still underway to determine the circumstances of the fire.”

The Traffic patrols, criminal patrols, rescue and ambulance teams, crime scene, air ... Read more »